Elena Yaiza Romero-Ventosa1, Marisol Samartín-Ucha2, Alicia Martín-Vila3, María Lucía Martínez-Sánchez4, Isabel Rey Gómez-Serranillos5, Guadalupe Pineiro-Corrales6. 1. Pharmacy Unit, Hospital Álvaro Cunqueiro, Vigo. Pontevedra.. yaiza_romero@hotmail.com. 2. Pharmacy Unit, Hospital Álvaro Cunqueiro, Vigo. Pontevedra.. Marisol.Samartin.Ucha@sergas.es. 3. Pharmacy Unit, Hospital Álvaro Cunqueiro, Vigo. Pontevedra.. alicia.martin.vila@sergas.es. 4. Primary Care in the Vigo Healthcare Area. Redondela Health Centre, Vigo. Pontevedra.. M.Lucia.Martinez.Sanchez@sergas.es. 5. Primary Care in the Vigo Healthcare Area. Department of Cases without Hospitalization and Emergencies, Vigo. Pontevedra. Spain. isabel.rey.gomez.serranillos@sergas.es. 6. Pharmacy Unit, Hospital Álvaro Cunqueiro, Vigo. Pontevedra.. guadalupe.pineiro.corrales@sergas.es.
Abstract
OBJECTIVE: To quantify Drug-Related problems (DRPs) by establishing a Strategic Continuity of Care Program (e-Conecta- Concilia Program; e-CC) focused on the drug therapy of patients within an Integrated Management Structure, in order to guarantee the therapeutical efficiency, safety and traceability of patients. METHOD: A prospective study at 8 months. The project included 22 Hospital Pharmacists and 12 Primary Care Pharmacists. Electronic clinical records were used, which can be accessed by all healthcare levels. Those interventions required in order to create a Standard Operating Procedure (SOP) were carried out (creation of working groups, computing, meeting points), for coordination among pharmacists in different care levels through a common communication system. The working groups formed by pharmacists of both care levels established the following inclusion criteria: patients with chronic diseases and polymedicated, patients for whom drug-related problems (DRP) had been detected, detection of any off-label use in Primary Care, or discrepancies in the standardization of medical prescriptions. RESULTS: In the setting of the e-CC program, interventions were unified and discrepancies were identified. During this project, 245 drug-related problems were detected; the majority regarding inadequate dosing, regimen, or duration (24%), and involving Group B medications (33%), according to the ATC classification. CONCLUSIONS: The implementation of a Continuity of Care SOP between pharmacists allowed to detect and solve DRPs and discrepancies in patient pharmacotherapy, with a high rate of acceptance (84.1%) of interventions. Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.
OBJECTIVE: To quantify Drug-Related problems (DRPs) by establishing a Strategic Continuity of Care Program (e-Conecta- Concilia Program; e-CC) focused on the drug therapy of patients within an Integrated Management Structure, in order to guarantee the therapeutical efficiency, safety and traceability of patients. METHOD: A prospective study at 8 months. The project included 22 Hospital Pharmacists and 12 Primary Care Pharmacists. Electronic clinical records were used, which can be accessed by all healthcare levels. Those interventions required in order to create a Standard Operating Procedure (SOP) were carried out (creation of working groups, computing, meeting points), for coordination among pharmacists in different care levels through a common communication system. The working groups formed by pharmacists of both care levels established the following inclusion criteria: patients with chronic diseases and polymedicated, patients for whom drug-related problems (DRP) had been detected, detection of any off-label use in Primary Care, or discrepancies in the standardization of medical prescriptions. RESULTS: In the setting of the e-CC program, interventions were unified and discrepancies were identified. During this project, 245 drug-related problems were detected; the majority regarding inadequate dosing, regimen, or duration (24%), and involving Group B medications (33%), according to the ATC classification. CONCLUSIONS: The implementation of a Continuity of Care SOP between pharmacists allowed to detect and solve DRPs and discrepancies in patient pharmacotherapy, with a high rate of acceptance (84.1%) of interventions. Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.
Authors: Manuel Vélez-Díaz-Pallarés; Ana María Álvarez Díaz; Teresa Gramage Caro; Noelia Vicente Oliveros; Eva Delgado-Silveira; María Muñoz García; Alfonso José Cruz-Jentoft; Teresa Bermejo-Vicedo Journal: Int J Clin Pharm Date: 2017-05-24
Authors: E Delgado-Silveira; M Vélez-Díaz-Pallarés; M Muñoz-García; A Correa-Pérez; A M Álvarez-Díaz; A J Cruz-Jentoft Journal: Eur Geriatr Med Date: 2021-05-07 Impact factor: 1.710